Newly published detailed clinical trial data show why Exelixis abandoned a plan to seek an FDA approval for a combination of ...

Doctors fear cancer patients missing out on correct care - The National Cancer Audit Collaborating Centre said prostate, kidney and colon cancers were the worst affected with variations in care.

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

Avelumab maintenance with axitinib interruption was feasible in metastatic renal cell carcinoma responders, according to ...

Senior doctors responsible for monitoring cancer care in England and Wales are concerned failings in NHS services are ...

In the initial publication in 2021, the KETYNOTE-564 trial demonstrated that adjuvant pembrolizumab was associated with ...

All nine patients treated with a personalized cancer vaccine following removal of their tumors remained cancer-free at a median data cut-off of 34.7 months.

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

Proactive onco-coaching did not improve quality of life but was linked to better overall survival in patients with metastatic ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk.

Deputy Steve Lyles has had a rare form of kidney cancer for the past five years. To help Lyles in his fight, the Waukesha ...